Hyderabad, Jan 14 (.) : Dr. Reddy’s Laboratories on Wednesday announced the first-to-market U.S. launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the generic equivalent of Extra-Strength Pataday® Once-Daily Relief, following approval by the U.S. Food and Drug Administration.
The over-the-counter (OTC) antihistamine eye drop is indicated for the temporary relief of itchy eyes caused by pollen, ragweed, grass, animal hair, and dander, the Hyderabad based pharma Giant said in a release. The product is available in a 2.5 mL bottle.
With this launch, Dr. Reddy’s expands its OTC eye-care portfolio, which already includes olopatadine ophthalmic solutions in 0.1% and 0.2% strengths.
The company highlighted the launch as a milestone in its strategy to deliver store-brand equivalents of leading OTC products in the U.S. market.
According to NielsenIQ data, the Pataday® brand recorded approximately $69.9 million in U.S. sales over the latest 52-week period ending December 27, 2025.
. KNR PRP